Background: Patients with chronic kidney disease (CKD) may need to have their radiopharmaceutical dosage adjusted to prevent adverse effects and poor outcomes, but there are few recommendations on radiopharmaceutical dosing for this group of patients. The aim of this study is to provide an overview of the available information on radiopharmaceutical dose recommendations for patients with CKD.
Methods: We performed a systematic literature review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.
The carrier dynamics in PF6 doped polypyrrole has been probed by dielectric spectroscopy (from 10(-4) to 4 eV), down to 4.2 K. The phase-sensitive sub-THz data have assisted to resolve the discrepancies in Kramers-Kronig analysis in earlier studies.
View Article and Find Full Text PDF